Intrinsiqs

Is Dyne Therapeutics, Inc. overvalued?

Dyne Therapeutics, Inc. (DYN) — key valuation metrics and fundamentals.

No verdict
Price
$21.12
Fair value
Current P/E
Normal P/E
Market cap
$3.43B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares DYN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.